{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T17:02:00Z","timestamp":1791997320181,"version":"4.4.0"},"reference-count":82,"publisher":"Public Library of Science (PLoS)","issue":"12","license":[{"start":{"date-parts":[[2019,12,31]],"date-time":"2019-12-31T00:00:00Z","timestamp":1577750400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","award":["SMN-139150"],"award-info":[{"award-number":["SMN-139150"]}],"id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003579","name":"University of Toronto","doi-asserted-by":"crossref","award":["Chair in Addiction, Department of Psychiatry"],"award-info":[{"award-number":["Chair in Addiction, Department of Psychiatry"]}],"id":[{"id":"10.13039\/501100003579","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Hugh Green Foundation","award":["Chair in Addiction Research, University of Auckland"],"award-info":[{"award-number":["Chair in Addiction Research, University of Auckland"]}]},{"name":"Correctional Service of Canada","award":["MOU # 15-070"],"award-info":[{"award-number":["MOU # 15-070"]}]}],"content-domain":{"domain":["www.plosmedicine.org"],"crossmark-restriction":false},"short-container-title":["PLoS Med"],"DOI":"10.1371\/journal.pmed.1003002","type":"journal-article","created":{"date-parts":[[2019,12,31]],"date-time":"2019-12-31T13:25:40Z","timestamp":1577798740000},"page":"e1003002","update-policy":"https:\/\/doi.org\/10.1371\/journal.pmed.corrections_policy","source":"Crossref","is-referenced-by-count":146,"title":["Opioid-related treatment, interventions, and outcomes among incarcerated persons: A systematic review"],"prefix":"10.1371","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7634-6671","authenticated-orcid":true,"given":"Monica","family":"Malta","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9580-8894","authenticated-orcid":true,"given":"Thepikaa","family":"Varatharajan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9634-9554","authenticated-orcid":true,"given":"Cayley","family":"Russell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michelle","family":"Pang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Bonato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2186-4030","authenticated-orcid":true,"given":"Benedikt","family":"Fischer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2019,12,31]]},"reference":[{"key":"pmed.1003002.ref001","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1002\/wps.20633","article-title":"Addressing the opioid crisis globally","volume":"18","author":"UNODC-WHO Informal Scientific Network","year":"2019","journal-title":"World Psychiatry"},{"key":"pmed.1003002.ref002","doi-asserted-by":"crossref","first-page":"293","DOI":"10.7326\/M17-0865","article-title":"Prescription opioid use, misuse, and use disorders in U.S. adults: 2015 National Survey on Drug Use and Health","volume":"167","author":"B Han","year":"2017","journal-title":"Ann Intern Med"},{"key":"pmed.1003002.ref003","unstructured":"Government of Canada. Opioid-related harms and deaths in Canada. Ottawa: Government of Canada; 2019 [cited 2019 Jun 4]. https:\/\/www.canada.ca\/en\/health-canada\/services\/substance-abuse\/prescription-drug-abuse\/opioids\/apparent-opioid-related-deaths.html."},{"key":"pmed.1003002.ref004","unstructured":"Substance Abuse and Mental Health Services Administration. Treatment Episode Data Set (TEDS) 2017: admissions to and discharges from publicly-funded substance use treatment. Rockville (MD): Substance Abuse and Mental Health Services Administration; 2019 [cited 2019 Jun 4]. https:\/\/www.samhsa.gov\/data\/sites\/default\/files\/cbhsq-reports\/TEDS-2017.pdf."},{"key":"pmed.1003002.ref005","doi-asserted-by":"crossref","first-page":"592","DOI":"10.7326\/0003-4819-159-9-201311050-00005","article-title":"Mortality after prison release: opioid overdose and other causes of death, risk factors, and time trends from 1999 to 2009","volume":"159","author":"IA Binswanger","year":"2013","journal-title":"Ann Intern Med"},{"key":"pmed.1003002.ref006","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1111\/j.1360-0443.2010.02990.x","article-title":"Meta-analysis of drug-related deaths soon after release from prison","volume":"105","author":"EL Merrall","year":"2010","journal-title":"Addiction"},{"key":"pmed.1003002.ref007","unstructured":"Bureau of Justice Statistics. Drug use, dependence, and abuse among state prisoners and jail inmates, 2007\u20132009. Washington (DC): Bureau of Justice Statistics; 2017 [cited 2019 Jun 4]. https:\/\/www.bjs.gov\/content\/pub\/pdf\/dudaspji0709.pdf."},{"key":"pmed.1003002.ref008","unstructured":"United Nations Office on Drugs and Crime. World drug report 2018. Vienna: United Nations Office on Drugs and Crime; 2018 [cited 2019 Jun 4]. https:\/\/www.unodc.org\/wdr2018\/index.html."},{"issue":"5","key":"pmed.1003002.ref009","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1080\/16066350500151739","article-title":"Substance use in prison: how much occurs and is it associated with psychopathology?","volume":"13","author":"AH Simpler","year":"2005","journal-title":"Addict Res Theory"},{"key":"pmed.1003002.ref010","doi-asserted-by":"crossref","first-page":"1725","DOI":"10.1111\/add.13877","article-title":"Substance use disorders in prisoners: an updated systematic review and meta-regression analysis in recently incarcerated men and women","volume":"112","author":"S Fazel","year":"2017","journal-title":"Addiction"},{"issue":"11","key":"pmed.1003002.ref011","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1007\/s11920-013-0414-z","article-title":"Treating substance use disorders in the criminal justice system","volume":"15","author":"S Belenko","year":"2013","journal-title":"Curr Psychiatry Rep"},{"key":"pmed.1003002.ref012","doi-asserted-by":"crossref","first-page":"419","DOI":"10.2105\/AJPH.2018.304852","article-title":"Criminal justice barriers to treatment of opioid use disorders in the United States: the need for public health advocacy","volume":"109","author":"J Csete","year":"2019","journal-title":"Am J Public Health"},{"key":"pmed.1003002.ref013","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.addbeh.2018.02.024","article-title":"Criminal justice continuum for opioid users at risk of overdose","volume":"86","author":"L Brinkley-Rubinstein","year":"2018","journal-title":"Addict Behav"},{"key":"pmed.1003002.ref014","doi-asserted-by":"crossref","DOI":"10.1093\/oso\/9780198818014.001.0001","volume-title":"Drug policy and the public good","author":"T Babor","year":"2018"},{"key":"pmed.1003002.ref015","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1056\/NEJMsa064115","article-title":"Release from prison\u2014a high risk of death for former inmates","volume":"356","author":"IA Binswanger","year":"2007","journal-title":"N Engl J Med"},{"key":"pmed.1003002.ref016","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1016\/j.addbeh.2012.01.019","article-title":"Incidence and risk factors for non-fatal overdose among a cohort of recently incarcerated illicit drug users","volume":"37","author":"SA Kinner","year":"2012","journal-title":"Addict Behav"},{"key":"pmed.1003002.ref017","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1046\/j.1360-0443.2003.00466.x","article-title":"Prior opiate injection and incarceration history predict injection drug use among inmates","volume":"98","author":"LM Calzavara","year":"2003","journal-title":"Addiction"},{"key":"pmed.1003002.ref018","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1093\/pubmed\/fdn021","article-title":"HIV risks associated with incarceration among injection drug users: implications for prison-based public health strategies","volume":"30","author":"D Werb","year":"2008","journal-title":"J Public Health (Oxf)"},{"key":"pmed.1003002.ref019","doi-asserted-by":"crossref","first-page":"j1550","DOI":"10.1136\/bmj.j1550","article-title":"Mortality risk during and after opioid substitution treatment: systematic review and meta-analysis of cohort studies","volume":"357","author":"L Sordo","year":"2017","journal-title":"BMJ"},{"key":"pmed.1003002.ref020","article-title":"Effects of medication-assisted treatment on mortality among opioids users: a systematic review and meta-analysis","author":"J Ma","year":"2018","journal-title":"Mol Psychiatry"},{"key":"pmed.1003002.ref021","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1186\/s12954-016-0118-x","article-title":"Overview of harm reduction in prisons in seven European countries","volume":"13","author":"G Sander","year":"2016","journal-title":"Harm Reduct J"},{"key":"pmed.1003002.ref022","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1080\/08897077.2011.611460","article-title":"Medication-assisted treatment in criminal justice agencies affiliated with the Criminal Justice\u2013Drug Abuse Treatment Studies (CJ-DATS): availability, barriers, and intentions","volume":"33","author":"PD Friedmann","year":"2012","journal-title":"Subst Abus"},{"issue":"2","key":"pmed.1003002.ref023","doi-asserted-by":"crossref","first-page":"e0192431","DOI":"10.1371\/journal.pone.0192431","article-title":"Physician prescribing of opioid agonist treatments in provincial correctional facilities in Ontario, Canada: a survey","volume":"13","author":"FG Kouyoumdjian","year":"2018","journal-title":"PLoS ONE"},{"key":"pmed.1003002.ref024","doi-asserted-by":"crossref","first-page":"219","DOI":"10.5055\/jom.2009.0024","article-title":"Overcoming obstacles to implementing methadone maintenance therapy for prisoners: implications for policy and practice","volume":"5","author":"M McKenzie","year":"2009","journal-title":"J Opioid Manag"},{"key":"pmed.1003002.ref025","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1111\/j.1360-0443.2011.03676.x","article-title":"The effectiveness of opioid maintenance treatment in prison settings: a systematic review","volume":"107","author":"D Hedrich","year":"2012","journal-title":"Addiction"},{"key":"pmed.1003002.ref026","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1001\/jamapsychiatry.2017.4614","article-title":"Postincarceration fatal overdoses after implementing medications for addiction treatment in a statewide correctional system","volume":"75","author":"TC Green","year":"2018","journal-title":"JAMA Psychiatry"},{"key":"pmed.1003002.ref027","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.jsat.2018.12.003","article-title":"Effectiveness of medication assisted treatment for opioid use in prison and jail settings: a meta-analysis and systematic review","volume":"99","author":"KE Moore","year":"2019","journal-title":"J Subst Abuse Treat"},{"issue":"4","key":"pmed.1003002.ref028","doi-asserted-by":"crossref","first-page":"e13","DOI":"10.2105\/AJPH.2014.302498","article-title":"A systematic review of randomized controlled trials of interventions to improve the health of persons during imprisonment and in the year after release","volume":"105","author":"FG Kouyoumdjian","year":"2015","journal-title":"Am J Public Health"},{"key":"pmed.1003002.ref029","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1016\/S2215-0366(16)30142-0","article-title":"Mental health of prisoners: prevalence, adverse outcomes, and interventions","volume":"3","author":"S Fazel","year":"2016","journal-title":"Lancet Psychiatry"},{"key":"pmed.1003002.ref030","first-page":"215","article-title":"Health status of prisoners in Canada: narrative review","volume":"62","author":"F Kouyoumdjian","year":"2016","journal-title":"Can Fam Physician"},{"key":"pmed.1003002.ref031","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1159\/000199046","article-title":"A literature review of international implementation of opioid substitution treatment in prisons: equivalence of care?","volume":"15","author":"S Larney","year":"2009","journal-title":"Eur Addict Res"},{"key":"pmed.1003002.ref032","doi-asserted-by":"crossref","unstructured":"Higgins JPT, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, et al., editors. Cochrane handbook for systematic reviews of interventions. Version 6.0, 2019. Cochrane Collaboration; 2019 [cited 2019 Nov 22]. https:\/\/www.training.cochrane.org\/handbook.","DOI":"10.1002\/9781119536604"},{"issue":"4","key":"pmed.1003002.ref033","doi-asserted-by":"crossref","first-page":"264","DOI":"10.7326\/0003-4819-151-4-200908180-00135","article-title":"Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement","volume":"151","author":"D Moher","year":"2009","journal-title":"Ann Intern Med"},{"key":"pmed.1003002.ref034","unstructured":"Joanna Briggs Institute. Critical appraisal tools. Adelaide: Joanna Briggs Institute; 2019 [cited 2019 Jun 4]. https:\/\/joannabriggs.org\/critical_appraisal_tools."},{"issue":"8","key":"pmed.1003002.ref035","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.1111\/add.12536","article-title":"The impact of opioid substitution therapy on mortality post-release from prison: retrospective data linkage study","volume":"109","author":"L Degenhardt","year":"2014","journal-title":"Addiction"},{"issue":"4","key":"pmed.1003002.ref036","doi-asserted-by":"crossref","first-page":"e004666","DOI":"10.1136\/bmjopen-2013-004666","article-title":"Opioid substitution therapy as a strategy to reduce deaths in prison: retrospective cohort study","volume":"4","author":"S Larney","year":"2014","journal-title":"BMJ Open"},{"key":"pmed.1003002.ref037","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.drugalcdep.2014.05.011","article-title":"A randomized controlled trial of prison-initiated buprenorphine: prison outcomes and community treatment entry","volume":"142","author":"MS Gordon","year":"2014","journal-title":"Drug Alcohol Depend"},{"issue":"4","key":"pmed.1003002.ref038","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1080\/10509674.2011.641075","article-title":"A randomized clinical trial of methadone maintenance for prisoners: prediction of treatment entry and completion in prison","volume":"51","author":"MS Gordon","year":"2012","journal-title":"J Offender Rehabil"},{"issue":"8","key":"pmed.1003002.ref039","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1111\/j.1360-0443.2008.002238.x","article-title":"A randomized clinical trial of methadone maintenance for prisoners: findings at 6 months post-release","volume":"103","author":"MS Gordon","year":"2008","journal-title":"Addiction"},{"key":"pmed.1003002.ref040","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.drugalcdep.2016.11.037","article-title":"A randomized clinical trial of buprenorphine for prisoners: findings at 12-months post-release","volume":"172","author":"MS Gordon","year":"2017","journal-title":"Drug Alcohol Depend"},{"key":"pmed.1003002.ref041","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.jsat.2015.07.005","article-title":"A phase 4, pilot, open-label study of VIVITROL(R) (extended-release naltrexone XR-NTX) for prisoners","volume":"59","author":"MS Gordon","year":"2015","journal-title":"J Subst Abuse Treat"},{"key":"pmed.1003002.ref042","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/j.drugalcdep.2018.04.010","article-title":"Initiating buprenorphine treatment prior to versus after release from prison: arrest outcomes","volume":"188","author":"MS Gordon","year":"2018","journal-title":"Drug Alcohol Depend"},{"issue":"1","key":"pmed.1003002.ref043","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1177\/0093854807309111","article-title":"A study of methadone maintenance for male prisoners: 3-month postrelease outcomes","volume":"35","author":"TW Kinlock","year":"2008","journal-title":"Crim Justice Behav"},{"issue":"3","key":"pmed.1003002.ref044","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.jsat.2009.03.002","article-title":"A randomized clinical trial of methadone maintenance for prisoners: results at 12 months postrelease","volume":"37","author":"TW Kinlock","year":"2009","journal-title":"J Subst Abuse Treat"},{"issue":"8","key":"pmed.1003002.ref045","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1080\/10509674.2013.782936","article-title":"Individual patient and program factors related to prison and community treatment completion in prison-initiated methadone maintenance treatment","volume":"52","author":"TW Kinlock","year":"2013","journal-title":"J Offender Rehabil"},{"issue":"1","key":"pmed.1003002.ref046","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1080\/08897077.2011.609446","article-title":"A randomized trial of methadone initiation prior to release from incarceration","volume":"33","author":"M McKenzie","year":"2012","journal-title":"Subst Abus"},{"issue":"2","key":"pmed.1003002.ref047","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.jsat.2013.02.005","article-title":"Initiation of buprenorphine during incarceration and retention in treatment upon release","volume":"45","author":"N Zaller","year":"2013","journal-title":"J Subst Abuse Treat"},{"key":"pmed.1003002.ref048","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.1056\/NEJMoa1505409","article-title":"Extended-release naltrexone to prevent opioid relapse in criminal justice offenders","volume":"374","author":"JD Lee","year":"2016","journal-title":"N Engl J Med"},{"key":"pmed.1003002.ref049","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.jsat.2017.04.010","article-title":"Initiation of extended release naltrexone (XR-NTX) for opioid use disorder prior to release from prison","volume":"85","author":"PD Friedmann","year":"2018","journal-title":"J Subst Abuse Treat"},{"key":"pmed.1003002.ref050","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.jsat.2017.05.009","article-title":"Healthcare utilization in adults with opioid dependence receiving extended release naltrexone compared to treatment as usual","volume":"85","author":"WE Soares","year":"2018","journal-title":"J Subst Abuse Treat"},{"key":"pmed.1003002.ref051","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1111\/j.1360-0443.2011.03618.x","article-title":"Effect of prison-based opioid substitution treatment and post-release retention in treatment on risk of re-incarceration","volume":"107","author":"S Larney","year":"2012","journal-title":"Addiction"},{"issue":"4","key":"pmed.1003002.ref052","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1159\/000357942","article-title":"Impact of methadone maintenance treatment on women offenders\u2019 post-release recidivism","volume":"20","author":"S Farrell-MacDonald","year":"2014","journal-title":"Eur Addict Res"},{"key":"pmed.1003002.ref053","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.jsat.2016.08.001","article-title":"Monitoring a prison opioid treatment program over a period of change to clinical governance arrangements, 2007\u20132013","volume":"70","author":"S Larney","year":"2016","journal-title":"J Subst Abuse Treat"},{"key":"pmed.1003002.ref054","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.1111\/add.12969","article-title":"Impact of opioid substitution therapy for Scotland\u2019s prisoners on drug-related deaths soon after prisoner release","volume":"110","author":"SM Bird","year":"2015","journal-title":"Addiction"},{"key":"pmed.1003002.ref055","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.jsat.2017.04.002","article-title":"Extended-release naltrexone for opioid use disorder started during or following incarceration","volume":"85","author":"T Lincoln","year":"2018","journal-title":"J Subst Abuse Treat"},{"key":"pmed.1003002.ref056","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1747-597X-4-1","article-title":"The Leeds Evaluation of Efficacy of Detoxification Study (LEEDS) prisons project: a randomised controlled trial comparing dihydrocodeine and buprenorphine for opiate detoxification","volume":"4","author":"L Sheard","year":"2009","journal-title":"Subst Abuse Treat Prev Policy"},{"key":"pmed.1003002.ref057","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.drugalcdep.2008.08.006","article-title":"Buprenorphine and methadone maintenance in jail and post-release: a randomized clinical trial","volume":"99","author":"S Magura","year":"2009","journal-title":"Drug Alcohol Depend"},{"issue":"3","key":"pmed.1003002.ref058","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1080\/02791072.2010.10400696","article-title":"Heroin-dependent inmates\u2019 experiences with buprenorphine or methadone maintenance","volume":"42","author":"E Awgu","year":"2010","journal-title":"J Psychoactive Drugs"},{"issue":"593","key":"pmed.1003002.ref059","doi-asserted-by":"crossref","first-page":"e772","DOI":"10.3399\/bjgp11X613106","article-title":"Comparison of methadone and buprenorphine for opiate detoxification (LEEDS trial): a randomised controlled trial","volume":"61","author":"NM Wright","year":"2011","journal-title":"Br J Gen Pract"},{"key":"pmed.1003002.ref060","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1016\/S0140-6736(14)62338-2","article-title":"Methadone continuation versus forced withdrawal on incarceration in a combined US prison and jail: a randomised, open-label trial","volume":"386","author":"JD Rich","year":"2015","journal-title":"Lancet"},{"key":"pmed.1003002.ref061","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.drugalcdep.2017.11.023","article-title":"A randomized, open label trial of methadone continuation versus forced withdrawal in a combined US prison and jail: findings at 12 months post-release","volume":"184","author":"L Brinkley-Rubinstein","year":"2018","journal-title":"Drug Alcohol Depend"},{"key":"pmed.1003002.ref062","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1097\/ADM.0000000000000381","article-title":"Feasibility and effectiveness of continuing methadone maintenance treatment during incarceration compared with forced withdrawal","volume":"12","author":"KE Moore","year":"2018","journal-title":"J Addict Med"},{"key":"pmed.1003002.ref063","doi-asserted-by":"crossref","first-page":"2017","DOI":"10.1111\/j.1360-0443.2008.02361.x","article-title":"The effect of a jail methadone maintenance therapy (MMT) program on inmate recidivism","volume":"103","author":"GP McMillan","year":"2008","journal-title":"Addiction"},{"key":"pmed.1003002.ref064","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1111\/j.1360-0443.2009.02558.x","article-title":"Maintenance therapy and 3-year outcome of opioid-dependent prisoners: a prospective study in France (2003\u201306)","volume":"104","author":"JN Marzo","year":"2009","journal-title":"Addiction"},{"key":"pmed.1003002.ref065","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1016\/j.drugalcdep.2013.01.005","article-title":"Methadone dose at the time of release from prison significantly influences retention in treatment: implications from a pilot study of HIV-infected prisoners transitioning to the community in Malaysia","volume":"132","author":"JA Wickersham","year":"2013","journal-title":"Drug Alcohol Depend"},{"key":"pmed.1003002.ref066","doi-asserted-by":"crossref","first-page":"124","DOI":"10.2471\/BLT.12.109132","article-title":"Implementing methadone maintenance treatment in prisons in Malaysia","volume":"91","author":"JA Wickersham","year":"2013","journal-title":"Bull World Health Organ"},{"key":"pmed.1003002.ref067","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jsat.2016.07.007","article-title":"Community-based methadone maintenance in a large detention center is associated with decreases in inmate recidivism","volume":"70","author":"VS Westerberg","year":"2016","journal-title":"J Subst Abuse Treat"},{"key":"pmed.1003002.ref068","doi-asserted-by":"crossref","first-page":"1408","DOI":"10.1111\/add.13779","article-title":"Does exposure to opioid substitution treatment in prison reduce the risk of death after release? A national prospective observational study in England","volume":"112","author":"J Marsden","year":"2017","journal-title":"Addiction"},{"key":"pmed.1003002.ref069","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1111\/j.1360-0443.2011.03443.x","article-title":"Mortality among a cohort of drug users after their release from prison: an evaluation of the effectiveness of a harm reduction program in Taiwan","volume":"106","author":"YF Huang","year":"2011","journal-title":"Addiction"},{"key":"pmed.1003002.ref070","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1080\/08897077.2011.620475","article-title":"Buprenorphine-naloxone maintenance following release from jail","volume":"33","author":"JD Lee","year":"2012","journal-title":"Subst Abus"},{"key":"pmed.1003002.ref071","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1177\/0093854813501495","article-title":"Assessing the impact of methadone maintenance treatment (MMT) on post-release recidivism among male federal correctional inmates in Canada","volume":"41","author":"M-A Macswain","year":"2014","journal-title":"Crim Justice Behav"},{"key":"pmed.1003002.ref072","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1353\/hpu.2014.0139","article-title":"Health outcomes and retention in care following release from prison for patients of an urban post-incarceration transitions clinic","volume":"25","author":"AD Fox","year":"2014","journal-title":"J Health Care Poor Underserved"},{"key":"pmed.1003002.ref073","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1080\/08897077.2016.1220443","article-title":"Recent incarceration and buprenorphine maintenance treatment outcomes among human immunodeficiency virus-positive patients","volume":"38","author":"DP Riggins","year":"2017","journal-title":"Subst Abus"},{"key":"pmed.1003002.ref074","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1111\/add.13265","article-title":"Effectiveness of Scotland\u2019s National Naloxone Programme for reducing opioid-related deaths: a before (2006\u201310) versus after (2011\u201313) comparison","volume":"111","author":"SM Bird","year":"2016","journal-title":"Addiction"},{"key":"pmed.1003002.ref075","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1016\/S0140-6736(17)30656-6","article-title":"Prison-based prescriptions aid Scotland\u2019s National Naloxone Programme","volume":"389","author":"SM Bird","year":"2017","journal-title":"Lancet"},{"key":"pmed.1003002.ref076","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1007\/s11524-010-9438-4","article-title":"Improved HIV and substance abuse treatment outcomes for released HIV-infected prisoners: the impact of buprenorphine treatment","volume":"87","author":"SA Springer","year":"2010","journal-title":"J Urban Health"},{"issue":"5","key":"pmed.1003002.ref077","doi-asserted-by":"crossref","first-page":"e38335","DOI":"10.1371\/journal.pone.0038335","article-title":"Retention on buprenorphine is associated with high levels of maximal viral suppression among HIV-infected opioid dependent released prisoners","volume":"7","author":"SA Springer","year":"2012","journal-title":"PLoS ONE"},{"key":"pmed.1003002.ref078","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1159\/000313336","article-title":"Naltrexone implants compared to methadone: outcomes six months after prison release","volume":"16","author":"PP Lobmaier","year":"2010","journal-title":"Eur Addict Res"},{"issue":"3","key":"pmed.1003002.ref079","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1111\/add.13668","article-title":"Randomized controlled pilot trial of naloxone-on-release to prevent post-prison opioid overdose deaths","volume":"112","author":"MK Parmar","year":"2017","journal-title":"Addiction"},{"key":"pmed.1003002.ref080","doi-asserted-by":"crossref","first-page":"1464","DOI":"10.1016\/S0140-6736(17)30259-3","article-title":"Mass incarceration, public health, and widening inequality in the USA","volume":"389","author":"C Wildeman","year":"2017","journal-title":"Lancet"},{"key":"pmed.1003002.ref081","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1177\/1073110518782933","article-title":"Our Ethical obligation to treat opioid use disorder in prisons: a patient and physician\u2019s perspective","volume":"46","author":"C Bone","year":"2018","journal-title":"J Law Med Ethics"},{"key":"pmed.1003002.ref082","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1056\/NEJMp1900069","article-title":"Opioid use disorder and incarceration\u2014hope for ensuring the continuity of treatment","volume":"380","author":"IA Binswanger","year":"2019","journal-title":"N Engl J Med"}],"container-title":["PLOS Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pmed.1003002","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,12,31]],"date-time":"2019-12-31T13:26:21Z","timestamp":1577798781000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pmed.1003002"}},"subtitle":[],"editor":[{"given":"Alexander C.","family":"Tsai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2019,12,31]]},"references-count":82,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2019,12,31]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pmed.1003002","relation":{},"ISSN":["1549-1676"],"issn-type":[{"value":"1549-1676","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,12,31]]}}}